AUTL – autolus therapeutics plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Autolus Therapeutics price target lowered to $10 from $11 at Truist [Yahoo! Finance]
Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Autolus Therapeutics plc (NASDAQ: AUTL) had its price target lowered by analysts at Truist Financial Co. from $11.00 to $10.00. They now have a "buy" rating on the stock.
Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025
CAR T-Cell Therapy Market Size To Reach 27.5 Billion by 2033 Owing to Rising Awareness and Favourable Reimbursement Policies Says Astute Analytica
Form SCHEDULE 13G/A Autolus Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 8-K Autolus Therapeutics For: Feb 28
Form EFFECT Autolus Therapeutics
Form POS AM Autolus Therapeutics
Form 10-K Autolus Therapeutics For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.